Related Experiment Video
Updated: Apr 21, 2026

07:00
In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
Published on: March 14, 2021
2.7K
Enhanced targeted drug delivery through controlled release in a three-dimensional vascular tree
Journal of Biomechanical Engineering
|November 4, 2014
Summary
This study optimizes drug delivery targeting in 3D vascular models using particle release mapping. It identified unique optimal injection sites under pulsatile flow, achieving 66% target efficiency.
Area of Science:
- Biomedical Engineering
- Computational Fluid Dynamics
- Pharmacology
Background:
- Optimizing drug delivery to specific targets within the vasculature is crucial for therapeutic efficacy.
- Current methods for determining optimal injection sites are limited, especially in complex 3D geometries.
- Particle release score map (PRSM) and transient particle release score map (TPRSM) offer a novel approach for controlled particle release and targeting.
Purpose of the Study:
- To investigate the feasibility of precise drug targeting in a complex 3D vascular tree model.
- To determine optimal drug injection locations for enhanced target efficiency (TE) under realistic hemodynamic conditions.
- To evaluate the influence of steady and pulsatile flow on particle release strategies.
Main Methods:
- Utilized a 3D vascular tree geometry with Poiseuille and Womersley velocity profiles for steady and pulsatile flow simulations, respectively.
- Modeled blood's non-Newtonian shear-thinning behavior using the Carreau-Yasuda model.
- Employed a one-way coupled Eulerian-Lagrangian particle tracking method to simulate drug particle trajectories.
Main Results:
- Particle size and density had minimal impact on drug particle trajectories.
- The optimal release scoring algorithm identified multiple optimal release locations under steady flow.
- A single, unique optimal release location was identified under pulsatile flow conditions.
- An average target efficiency of 66% was achieved in pulsatile flow simulations.
Conclusions:
- The proposed particle release and targeting technique shows promise for optimizing drug delivery in complex vascular networks.
- The study highlights the importance of flow dynamics (steady vs. pulsatile) in determining optimal injection strategies.
- Further mathematical modeling refinement and experimental validation are warranted to advance this in silico approach.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
160
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
160
Site-Targeted Drug Delivery Systems: Polymeric Carriers
146
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
146
Modified-Release Drug Delivery Systems: Classification
301
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
301
Modified-Release Drug Delivery Systems: Rate-Programmed II
127
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
127
Modified-Release Drug Delivery Systems: Rate-Programmed I
167
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
167
Modified-Release Drug Delivery Systems: Overview
226
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
226

